Chromatographic techniques in analysis of cyclooxygenase-2 inhibitors in drugs and biological samples

被引:4
作者
Starek, Malgorzata [1 ]
Dabrowska, Monika [1 ]
机构
[1] Jagiellonian Univ, Dept Inorgan & Analyt Chem, Coll Med, Fac Pharm, PL-30688 Krakow, Poland
来源
CENTRAL EUROPEAN JOURNAL OF CHEMISTRY | 2012年 / 10卷 / 03期
关键词
COX-2; inhibitors; Analysis; Chromatography; Stability; Pharmacokinetic; PERFORMANCE LIQUID-CHROMATOGRAPHY; ULTRAVIOLET ABSORBENCY DETECTION; PROCESS-RELATED IMPURITIES; INDICATING HPLC METHOD; HUMAN PLASMA; MASS-SPECTROMETRY; BULK DRUG; DEGRADATION-PRODUCTS; SELECTIVE INHIBITOR; COX-2; INHIBITOR;
D O I
10.2478/s11532-012-0029-y
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Non-steroidal anti-inflammatory drugs, as a therapeutic class, are among the most often used active pharmaceutical ingredients in heath care in the world. They are mostly available without prescription and often used for treatment of fever and pain. An extensive research of the literature published in analytical and pharmaceutical chemistry journals has been conducted and the chromatographic methods which were used for the purity, stability and pharmacokinetic studies of the cyclooxygenase-2 inhibitors, in formulations and biological materials have been reviewed. The methodology for the analysis of selected drugs is very well documented and many examples are available in the literature. The common use of chromatographic techniques with various detection attachments provide possibility for monitoring of drugs in therapy.
引用
收藏
页码:711 / 730
页数:20
相关论文
共 77 条
[1]   Liquid chromatographic-mass spectrometric determination of celecoxib in plasma using single-ion monitoring and its use in clinical pharmacokinetics [J].
Abdel-Hamid, M ;
Novotny, L ;
Hamza, H .
JOURNAL OF CHROMATOGRAPHY B, 2001, 753 (02) :401-408
[2]   Development of a derivatization method, coupled with reverse phase HPLC, for monitoring the formation of an enolate intermediate [J].
Abrahim, A ;
Hartman, R ;
Ge, Z ;
Mao, B ;
Marcoux, J .
JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, 2002, 25 (07) :1049-1062
[3]   Pre-column derivatization of rofecoxib for determination in serum by HPLC [J].
Amini, M ;
Hamedani, MP ;
Vosooghi, M ;
Nabavi, M ;
Shafiee, A .
ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2005, 382 (05) :1265-1268
[4]  
Baboota S, 2007, ACTA CHROMATOGR, V18, P116
[5]   Rofecoxib is a potent inhibitor of cytochrome P450 1A2: studies with tizanidine and caffeine in healthy subjects [J].
Backman, Janne T. ;
Karjalainen, Marjo J. ;
Neuvonen, Mikko ;
Laitila, Jouko ;
Neuvonen, Pertti J. .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (03) :345-357
[6]   Stability-indicating methods for the determination of doxazosin mezylate and celecoxib [J].
Bebawy, LI ;
Moustafa, AA ;
Abo-Talib, NF .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2002, 27 (05) :779-793
[7]  
Carlucci Giuseppe, 2009, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V8, P22
[8]   High-performance liquid chromatographic-tandem mass spectrometric evaluation and determination of stable isotope labeled analogs of rofecoxib in human plasma samples from oral bioavailability studies [J].
Chavez-Eng, CM ;
Constanzer, ML ;
Matuszewski, BK .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2002, 767 (01) :117-129
[9]   A stability-indicating HPLC method to determine celecoxib in capsule formulations [J].
Dhabu, PM ;
Akamanchi, KG .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2002, 28 (07) :815-821
[10]   Preparation of 125I-celecoxib with high purity as a possible tumor agent [J].
El-Azony, K. M. .
JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY, 2010, 285 (02) :315-320